Biotechnology company Dermata Therapeutics, developing drugs for the treatment of skin diseases based on badyagi in 3 research phase, attracted 18 million dollars, releasing 2,6 million packages of 7 dollars - the minimum price of the stated range from 7 to 9 Dollars.
9 August biotech company Eliem Therapeutics, developing drugs for the treatment of disorders of nervous excitability in phase 2a research, announced a reduction in the size of the upcoming IPO.
Biotechnology company IN8bio, develops allogeneic drugs for cancer treatment based on gamma-delta T cells, located in 1 research phase, attracted 40 million dollars, releasing 4 million shares in 10 dollars - the minimum price of the stated range from 10 to 12 Dollars.
Biotechnology company Omega Therapeutics, developing gene therapy for cancer and other diseases in the preclinical stage of research, attracted 126 million dollars, releasing 7,4 million shares in 17 dollars - within the stated range from 16 to 18 Dollars.
Preclinical Biotechnology Company Immuneering, specializing in influencing signaling pathways for the treatment of cancer and neurological diseases, attracted 113 million dollars, releasing 7,5 million shares in 15 dollars - within the stated range from 14 to 16 Dollars.
Компания Rani Therapeutics, developing capsules for oral medication by swallowing, attracted 73 million dollars, releasing 6,7 million shares in 11 dollars - below the stated range from 14 to 16 Dollars. Taking into account the actual IPO price, the total diluted market value of the company was 528 million dollars.
2 August biotech company Adagio Therapeutics, developing antibodies for the treatment of COVID-19 and other infectious diseases in 1 research phase, announced the terms of the upcoming IPO.
2 August biotech company Eliem Therapeutics, developing drugs for the treatment of disorders of nervous excitability in phase 2a research, announced the terms of the upcoming IPO. Company headquartered in Redmond, Washington State, plans to attract 81 million dollars, releasing 4,5 million shares at a price from 17 to 19 Dollars.
3 August Tivic Health Systems, commercializing a bioelectronic device for the treatment of nasal and sinus inflammation, filed an application with the Securities and Exchange Commission to raise up to 16 million dollars.
Comic publisher, graphic novels and art books by IDW Media Holdings 9 million dollars, releasing 2,5 million shares in 3,60 dollars - below the closing price of its OTC stock (IDWM), constituted 3,95 dollar. The company offered at 0,25 million shares more, than planned.